Qualigen Therapeutics Equity 2024

Qualigen Therapeutics Aktienanalyse

What does Qualigen Therapeutics do?

Qualigen Therapeutics is a company that specializes in the development and production of innovative therapeutics, diagnostics, and medical devices. It was founded in 1995 and has since become a major player in the bio-pharmaceutical industry. The company focuses on the development of oncology products and has expanded its portfolio to include a wide range of products and services for various disease conditions. It markets its products and services through collaborations with institutions and companies worldwide. The company is divided into different divisions, including oncology, infectious diseases, immunology, and metabolic disorders, each offering innovative products and services tailored to specific clinical needs. In the oncology division, Qualigen Therapeutics develops therapeutics for the treatment of cancer, including a novel lung cancer medication. It has also developed a promising therapy for COVID-19. In the infectious diseases division, the company focuses on the development of diagnostics and therapeutics for the treatment of infectious diseases, such as a rapid HIV test and a novel medication for tuberculosis. The immunology division focuses on the development of diagnostics and therapeutics for autoimmune diseases, including a diagnostic test for rheumatoid arthritis and a novel medication for multiple sclerosis. In the metabolic disorders division, the company develops diagnostics and therapeutics for conditions like diabetes, including a diagnostic test for diabetes and a novel medication for obesity. Qualigen Therapeutics is an innovative and forward-thinking company that specializes in the development and production of therapeutics, diagnostics, and medical devices. It collaborates with various institutions and companies worldwide to market its products and services. Its different divisions offer a wide range of innovative products and services tailored to specific clinical needs. Qualigen Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Qualigen Therapeutics's Equity

Qualigen Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Qualigen Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Qualigen Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Qualigen Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Qualigen Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Qualigen Therapeutics Stock

What is the equity of Qualigen Therapeutics this year?

Qualigen Therapeutics has equity of -2.1 M USD this year.

What was the equity of Qualigen Therapeutics compared to the previous year?

The equity of Qualigen Therapeutics has increased/decreased by -129.05% decreased compared to the previous year.

What impact does a high equity have on investors of Qualigen Therapeutics?

A high equity is advantageous for investors of Qualigen Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Qualigen Therapeutics?

A low equity can be a risk for investors of Qualigen Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Qualigen Therapeutics affect the company?

An increase in equity of Qualigen Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Qualigen Therapeutics affect the company?

A reduction in equity of Qualigen Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Qualigen Therapeutics?

Some factors that can affect the equity of Qualigen Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Qualigen Therapeutics so important for investors?

The equity of Qualigen Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Qualigen Therapeutics take to change the equity?

To change equity, Qualigen Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Qualigen Therapeutics pay?

Over the past 12 months, Qualigen Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Qualigen Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Qualigen Therapeutics?

The current dividend yield of Qualigen Therapeutics is .

When does Qualigen Therapeutics pay dividends?

Qualigen Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Qualigen Therapeutics?

Qualigen Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Qualigen Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Qualigen Therapeutics located?

Qualigen Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Qualigen Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Qualigen Therapeutics from 7/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Qualigen Therapeutics pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Qualigen Therapeutics in the year 2023?

In the year 2023, Qualigen Therapeutics distributed 0 USD as dividends.

In which currency does Qualigen Therapeutics pay out the dividend?

The dividends of Qualigen Therapeutics are distributed in USD.